Chiropractors in Central Islip, NY Accepting Medicare
5 Chiropractors found. Showing 1 - 5
 Island Care Chiropractic Of Suffolk Pc Chiropractor Medicare: Not Enrolled in Medicare Practice Location: 100 W Suffolk Ave Unit G, Central Islip, NY 11722 Phone: 631-388-1188 |
 Dr. Erik Thomas Knudsen, DC Chiropractor Medicare: Not Enrolled in Medicare Practice Location: 2226 Finch Ln, Central Islip, NY 11722 Phone: 631-374-4241 |
 Dr. Roberta Lynn Peets, DC Chiropractor Medicare: Accepting Medicare Assignments Practice Location: 100 W Suffolk Ave Unit G, Central Islip, NY 11722 Phone: 631-993-5400 |
Dr. Emely A. Flores, D.C. Chiropractor Medicare: Not Enrolled in Medicare Practice Location: 258 E Suffolk Ave, Central Islip, NY 11722 Phone: 631-348-6780 Fax: 631-348-6780 |
Dr. Gregory Paul Krumholz, D.C. Chiropractor Medicare: Accepting Medicare Assignments Practice Location: 258 E Suffolk Ave, Central Islip, NY 11722 Phone: 631-348-6780 Fax: 631-348-6780 |
News Archive
Patients with multiple colorectal adenomas may carry germline mutations in APC or MUTYH genes
Among patients with multiple colorectal polyps, the prevalence of certain gene mutations varied considerably by polyp count, according to a study in the August 1 issue of JAMA.
Researchers discover new factors that regulate fat formation
By creating a "map" of histone modifications in fat cells, investigators have discovered two new factors that regulate fat formation, a key step on the road to better understanding obesity, diabetes and other metabolic disorders.
New bacterial species may help fight obesity and metabolic disorders
The MyNewGut project has discovered new bacterial species and strains in healthy people that seem to be effective against obesity, metabolic and mental disorders related to stress and obesity (e.g. depression).
Immunotherapy combination shrinks rare angiosarcoma tumors in 25% of patients
Researchers from SWOG Cancer Research Network, a cancer clinical trials group funded by the National Cancer Institute's Division of Cancer Diagnosis and Treatment, part of the National Institutes of Health, have shown that the immunotherapy combination of ipilimumab and nivolumab shrinks rare angiosarcoma tumors in 25 percent of all patients, with some having an even stronger response to the drug combination.
› Verified 3 days ago
Speech-Language Pathologists
Chiropractors
Physical Therapists
Occupational Therapists
Audiologists